Showing 1351-1360 of 19239 results for "".
IL-17A Inhibition and the Stress Response in Psoriasis
https://reachmd.com/programs/Audioabstracts/il-17a-inhibition-stress-response-psoriasis/39684/When prescribing secukinumab, we focus on IL-17A blockade to clear psoriatic plaques—but could this targeted therapy also influence the body’s stress system? Join Ryan Quigley as he walks through a 16-week clinical study exploring how IL-17A inhibition affects the hypothalamic–pituitary–adrenal axisShifting the Script: How Inner Dialogue Influences Psoriasis Progress
https://reachmd.com/programs/frontlines-psoriasis/inner-dialogue-psoriasis-progress/39949/A patient’s inner dialogue—especially negative self-talk—can influence their perception of disease, adherence to treatment, and emotional wellbeing. Ryan Quigley sits down with Dr. Michael Greenberg, a dermatologist at the Illinois Dermatology Institute, as he shares observations from his own practiGenetic Testing in Pediatrics: Identifying Neurodevelopmental Disorders Early
https://reachmd.com/programs/clinicians-roundtable/genetic-testing-in-pediatrics-identifying-neurodevelopmental-disorders-early/37129/Early genetic evaluation plays a vital role in identifying potential causes of neurodevelopmental disorders and guiding families on next steps, expectations, and recurrence risks. Dr. Jennifer Kalish joins us to share practical insights for recognizing when to initiate testing, selecting theImproving Treatment Adherence in Pediatric Atopic Dermatitis
https://reachmd.com/programs/clinicians-roundtable/improving-treatment-adherence-in-pediatric-atopic-dermatitis/36443/Clear communication, education, and follow-up are central to managing pediatric atopic dermatitis effectively and improving treatment adherence. Discover practical strategies for working with families and optimizing care plans with Dr. Nicole Harter. Dr. Harter is an Associate Professor in the DeparGene Therapy Safety in DMD: How to Identify Common Immune Reactions
https://reachmd.com/programs/neurofrontiers/gene-therapy-safety-in-dmd-how-to-identify-common-immune-reactions/35681/Gene therapy for Duchenne muscular dystrophy (DMD) introduces a micro-dystrophin transgene to support improved protein production, but it’s not without serious risks, including myocarditis, hepatic inflammation, and myositis. Here to help raise awareness of the common immune complications associatedNew Frontiers in the Imaging and Treatment of Advanced Prostate Cancer
https://reachmd.com/programs/frontlines-prostate-cancer/new-frontiers-in-the-imaging-and-treatment-of-advanced-prostate-cancer/32221/From PSMA imaging to precision medicine strategies based on molecular drivers, novel diagnostics and therapies are reshaping the way we care for men with advanced prostate cancer. But despite these advancements, certain challenges and unmet needs remain. Joining Dr. Wayne Kuang to talk about these eInvestigating Inebilizumab for Generalized Myasthenia Gravis: Results from MINT
https://reachmd.com/programs/neurofrontiers/investigating-inebilizumab-for-generalized-myasthenia-gravis-results-from-mint/35495/Recently published in The New England Journal of Medicine, the phase 3 Myasthenia Gravis Inebilizumab Trial (MINT) underscores the potential of inebilizumab as a therapeutic option for patients with generalized myasthenia gravis (gMG). This is based on the efficacy findings that inebilizumab signifiUnraveling the Mechanism: How Ocrelizumab Impacts Cortical Lesions in MS
https://reachmd.com/programs/neurofrontiers/unraveling-the-mechanism-how-ocrelizumab-impacts-cortical-lesions-in-ms/32367/While B-cell follicles in the brain’s meninges were previously suspected to drive cortical lesions in multiple sclerosis (MS), studies show ocrelizumab has little impact on B-cell follicles—yet it still significantly reduces cortical lesions. This suggests that another, yet-to-be-understood B-cell-mCognitive Impairment in MS: Mitigating Impacts to Optimize Brain Health
https://reachmd.com/programs/neurofrontiers/cognitive-impairment-in-ms-mitigating-impacts-to-optimize-brain-health/32370/Learn about how cognitive impairment can affect patients with multiple sclerosis and discover ways to support their cognitive function.Multiple Sclerosis Explained: Understanding Its Epidemiology
https://reachmd.com/programs/neurofrontiers/multiple-sclerosis-explained-understanding-its-epidemiology/32371/Hear about how multiple sclerosis impacts patients, and learn about genetic and environmental factors associated with the onset of the disease.